• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞减少与川崎病患者的预后无关。

Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease.

作者信息

Tang Yunjia, Gang Miao, Qian Weiguo, Ma Jin, Xu Qiuqin, Lv Haitao

机构信息

Department of Cardiology, Children's Hospital of Soochow University, Suzhou, China.

Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, China.

出版信息

Front Pediatr. 2021 Jun 4;9:652346. doi: 10.3389/fped.2021.652346. eCollection 2021.

DOI:10.3389/fped.2021.652346
PMID:34150684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8211881/
Abstract

To investigate the outcomes of coronary artery lesions (CALs) and intravenous immunoglobulin (IVIG) resistance in patients with and without neutropenia during the disease course and to explore the relationships between Δ absolute neutrophils count (ΔANC) and the outcomes. We retrospectively reviewed the medical records of patients hospitalized in Children's Hospital of Soochow University with a main diagnosis of KD during January 2019 and December 2019. 1:4 propensity score matching was carried out to adjust the baseline characteristics. Smoothed plots and threshold effect analyses were performed to reveal the relationships between ΔANC and the outcomes. Of the 438 patients enrolled, 75 (17.1%) were neutropenia cases and 363 (82.9%) were non-neutropenia cases. Patients with neutropenia were younger, had lower levels of initial ANC, white blood cell (WBC) count and C-reactive protein (CRP). Propensity score matching included 75 neutropenia and 247 non-neutropenia patients. No significant difference was found between neutropenia and non-neutropenia groups regarding CALs, coronary artery aneurysms, irregular coronary lumen, IVIG resistance and days of fever duration. There was a non-linear relationship between ΔANC and IVIG resistance. However, threshold effect analysis showed the incidence of IVIG resistance decreased with increasing ΔANC before the turning point (ΔANC = 1.6) (OR = 0.65, 95% CI = 0.50-0.8.4 = 0.001). On the other hand, there was a linear relationship between ΔANC and CALs, even after adjusting the confounders (OR = 1.06, 95% CI = 1.02-1.11, = 0.008). Neutropenia after IVIG was not exactly associated with the outcomes. However, ΔANC was in relation to CALs and IVIG resistance.

摘要

研究疾病过程中伴有和不伴有中性粒细胞减少症的患者冠状动脉病变(CALs)及静脉注射免疫球蛋白(IVIG)抵抗的结局,并探讨绝对中性粒细胞计数变化量(ΔANC)与结局之间的关系。我们回顾性分析了2019年1月至2019年12月在苏州大学附属儿童医院住院且主要诊断为川崎病(KD)患者的病历。采用1:4倾向评分匹配法调整基线特征。进行平滑曲线分析和阈值效应分析以揭示ΔANC与结局之间的关系。在纳入的438例患者中,75例(17.1%)为中性粒细胞减少症病例,363例(82.9%)为非中性粒细胞减少症病例。中性粒细胞减少症患者年龄更小,初始ANC、白细胞(WBC)计数和C反应蛋白(CRP)水平更低。倾向评分匹配纳入了75例中性粒细胞减少症患者和247例非中性粒细胞减少症患者。中性粒细胞减少症组与非中性粒细胞减少症组在CALs、冠状动脉瘤、冠状动脉管腔不规则、IVIG抵抗及发热持续天数方面未发现显著差异。ΔANC与IVIG抵抗之间存在非线性关系。然而,阈值效应分析显示,在转折点(ΔANC = 1.6)之前,IVIG抵抗的发生率随ΔANC升高而降低(OR = 0.65,95%CI = 0.50 - 0.84,P = 0.001)。另一方面,即使在调整混杂因素后,ΔANC与CALs之间仍存在线性关系(OR = 1.06,95%CI = 1.02 - 1.11,P = 0.008)。IVIG治疗后出现的中性粒细胞减少症与结局并无确切关联。然而,ΔANC与CALs及IVIG抵抗有关。

相似文献

1
Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease.中性粒细胞减少与川崎病患者的预后无关。
Front Pediatr. 2021 Jun 4;9:652346. doi: 10.3389/fped.2021.652346. eCollection 2021.
2
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.川崎病中静脉注射免疫球蛋白抵抗及冠状动脉病变的预测因素
Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.
3
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?英夫利昔单抗联合静脉注射免疫球蛋白(IVIG)与单独 IVIG 作为有冠状动脉损伤的川崎病患儿初始治疗的比较:双治疗更有效吗?
Pediatr Infect Dis J. 2018 Oct;37(10):976-980. doi: 10.1097/INF.0000000000001951.
4
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
5
Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.土耳其儿童川崎病:单中心经验,重点关注静脉注射免疫球蛋白抵抗和巨大冠状动脉瘤
Turk J Pediatr. 2019;61(5):648-656. doi: 10.24953/turkjped.2019.05.002.
6
Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study.川崎病患者白蛋白水平与冠状动脉病变进展:一项回顾性队列研究。
Front Pediatr. 2022 Sep 14;10:947059. doi: 10.3389/fped.2022.947059. eCollection 2022.
7
A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.一项前瞻性研究比较了川崎病患者血清 IL6 和 CRP 水平与冠状动脉变化和治疗反应的关系。
Rheumatol Int. 2019 Oct;39(10):1797-1801. doi: 10.1007/s00296-019-04375-9. Epub 2019 Jul 13.
8
Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease.确定小林、佐野和江上标准与伊朗川崎病患儿静脉注射免疫球蛋白抵抗及冠状动脉瘤患病率之间的关系。
Open Access Rheumatol. 2020 Aug 26;12:187-192. doi: 10.2147/OARRR.S255138. eCollection 2020.
9
Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白抵抗及冠状动脉病变与Th1/Th2细胞因子谱的关系评估
Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.
10
Tenascin-C predicts IVIG non-responsiveness and coronary artery lesions in kawasaki disease in a Chinese cohort.在中国队列中,肌腱蛋白-C可预测川崎病患儿静脉注射免疫球蛋白无反应性及冠状动脉病变。
Front Pediatr. 2022 Dec 13;10:979026. doi: 10.3389/fped.2022.979026. eCollection 2022.

本文引用的文献

1
Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.中性粒细胞与淋巴细胞比值及其评分系统对川崎病冠状动脉病变的预测价值。
BMC Pediatr. 2020 Aug 24;20(1):398. doi: 10.1186/s12887-020-02285-5.
2
Kawasaki disease: pathophysiology and insights from mouse models.川崎病:病理生理学和来自小鼠模型的见解。
Nat Rev Rheumatol. 2020 Jul;16(7):391-405. doi: 10.1038/s41584-020-0426-0. Epub 2020 May 26.
3
Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.2013 年至 2017 年上海川崎病的流行病学特征。
J Epidemiol. 2020 Oct 5;30(10):429-435. doi: 10.2188/jea.JE20190065. Epub 2019 Sep 21.
4
TNF and IL-1 Play Essential but Temporally Distinct Roles in Driving Cardiac Inflammation in a Murine Model of Kawasaki Disease.TNF 和 IL-1 在川崎病小鼠模型中驱动心脏炎症中发挥重要但时间上不同的作用。
J Immunol. 2019 Jun 1;202(11):3151-3160. doi: 10.4049/jimmunol.1801593. Epub 2019 Apr 17.
5
Age- and sex-specific reference intervals for hematologic analytes in Chinese children.中国儿童血液分析物的年龄和性别特异性参考区间。
Int J Lab Hematol. 2019 Jun;41(3):331-337. doi: 10.1111/ijlh.12979. Epub 2019 Feb 20.
6
A critical appraisal of the role of intracellular Ca-signaling pathways in Kawasaki disease.细胞内钙信号通路在川崎病中的作用评价。
Cell Calcium. 2018 May;71:95-103. doi: 10.1016/j.ceca.2018.01.002. Epub 2018 Feb 3.
7
Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.静脉注射免疫球蛋白治疗后中性粒细胞减少与川崎病患儿冠状动脉病变的相关性:一项病例对照研究
BMC Pediatr. 2018 Feb 21;18(1):76. doi: 10.1186/s12887-018-1032-z.
8
On What Day of Illness Does the Dilatation of Coronary Arteries in Patients With Kawasaki Disease Begin?川崎病患者冠状动脉扩张起始于发病第几天?
Circ J. 2017 Dec 25;82(1):247-250. doi: 10.1253/circj.CJ-17-0046. Epub 2017 Aug 25.
9
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
10
Autoimmune and other acquired neutropenias.自身免疫性及其他获得性中性粒细胞减少症。
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):38-42. doi: 10.1182/asheducation-2016.1.38.